Core Viewpoint - The company has approved an increase in the expected daily related party transaction limit for 2025, amounting to 4.5 million RMB, which is based on normal business operations and market pricing, ensuring no impact on the company's independence or shareholder interests [1][2]. Summary by Sections Daily Related Party Transactions - The company held board meetings on August 27, 2025, where the proposal to increase the daily related party transaction limit was unanimously approved by non-related directors and all supervisors [1]. - The newly added daily related party transaction limit for 2025 is 4.5 million RMB, which is a part of the company's normal business operations [1][2]. Transaction Details - The expected categories and amounts of the related party transactions include sales of products to related parties, with a total expected transaction amount of 17.975 million RMB for 2025, which includes the newly added limit [2][5]. - The breakdown of the expected related party transactions includes sales to Shanghai Pinde Aohua Medical Equipment Co., Ltd. and Hangzhou Kangrui Medical Equipment Co., Ltd., with specific amounts detailed in the report [2][5]. Related Party Information - Shanghai Pinde Aohua Medical Equipment Co., Ltd. is a subsidiary in which the company holds a 33.33% stake, and it has total assets of approximately 17.12 million RMB as of December 31, 2024 [3][4]. - Hangzhou Kangrui Medical Equipment Co., Ltd. has a registered capital of 6 million RMB and is involved in the sale of medical devices [3][4]. Purpose and Impact of Transactions - The increase in daily related party transaction limits is aimed at facilitating the company's normal business activities and promoting related business development [5]. - The company emphasizes that all transactions will adhere to fair pricing principles and will not compromise the interests of shareholders, particularly minority shareholders [5].